BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20470217)

  • 1. Radioimmunotherapy for the treatment of non-Hodgkin lymphoma: current status and future applications.
    Ahmed S; Winter JN; Gordon LI; Evens AM
    Leuk Lymphoma; 2010 Jul; 51(7):1163-77. PubMed ID: 20470217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunotherapy for indolent B-cell non-Hodgkin lymphoma in relapsed, refractory and transformed disease.
    Visser OJ; Perk LR; Zijlstra JM; van Dongen GA; Huijgens PC; van de Loosdrecht AA
    BioDrugs; 2006; 20(4):201-7. PubMed ID: 16831019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine-131 rituximab radioimmunotherapy with BEAM conditioning and autologous stem cell transplant salvage therapy for relapsed/refractory aggressive non-Hodgkin lymphoma.
    Kruger PC; Cooney JP; Turner JH
    Cancer Biother Radiopharm; 2012 Nov; 27(9):552-60. PubMed ID: 23062193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunotherapy for B-cell non-hodgkin lymphomas.
    Tomblyn M
    Cancer Control; 2012 Jul; 19(3):196-203. PubMed ID: 22710895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunotherapy for non-hodgkin lymphoma : historical perspective and current status.
    Emmanouilides C
    J Clin Exp Hematop; 2007 Nov; 47(2):43-60. PubMed ID: 18040144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunotherapy for Non-Hodgkin's Lymphoma.
    Rao AV; Akabani G; Rizzieri DA
    Clin Med Res; 2005 Aug; 3(3):157-65. PubMed ID: 16160070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of radioimmunotherapy with yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma.
    Cheson BD
    BioDrugs; 2005; 19(5):309-22. PubMed ID: 16207072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-myeloablative radioimmunotherapy for non-Hodgkin's lymphoma.
    Schaefer-Cutillo J; Friedberg JW
    Semin Hematol; 2008 Apr; 45(2):110-7. PubMed ID: 18381106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunotherapy in non-Hodgkin lymphoma: Prediction and assessment of response.
    Eskian M; Khorasanizadeh M; Kraeber-Bodere F; Rezaei N
    Crit Rev Oncol Hematol; 2016 Nov; 107():182-189. PubMed ID: 27823646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunotherapy as the first line of treatment in non-Hodgkin lymphoma.
    Eskian M; Khorasanizadeh M; Zinzani PL; Rezaei N
    Immunotherapy; 2018 Jun; 10(8):699-711. PubMed ID: 29569511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Methods to Improve the Efficiency of Radioimmunotherapy for Non-Hodgkin Lymphoma.
    Eskian M; Khorasanizadeh M; Zinzani PL; Illidge TM; Rezaei N
    Int Rev Immunol; 2019; 38(2):79-91. PubMed ID: 30931651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunotherapy for stem cell transplantation in non-Hodgkin's lymphoma: in pursuit of a complete response.
    Gisselbrecht C; Vose J; Nademanee A; Gianni AM; Nagler A
    Oncologist; 2009; 14 Suppl 2():41-51. PubMed ID: 19819923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.
    Wiseman GA; Kornmehl E; Leigh B; Erwin WD; Podoloff DA; Spies S; Sparks RB; Stabin MG; Witzig T; White CA
    J Nucl Med; 2003 Mar; 44(3):465-74. PubMed ID: 12621016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative Setting.
    Cicone F; Sarnelli A; Guidi C; Belli ML; Ferrari ME; Wahl R; Cremonesi M; Paganelli G
    Semin Nucl Med; 2022 Mar; 52(2):191-214. PubMed ID: 34996594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunotherapy of non-Hodgkin's lymphoma: from the 'magic bullets' to 'radioactive magic bullets'.
    Chamarthy MR; Williams SC; Moadel RM
    Yale J Biol Med; 2011 Dec; 84(4):391-407. PubMed ID: 22180677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of radioimmunotherapy (RIT) in treatment of non-Hodgkin's lymphoma in the community setting.
    Hadid T; Raufi A; Kafri Z; Mandziara M; Kalabat J; Szpunar S; Kolizeras K; Steigelman M; Al-Katib A
    Nucl Med Biol; 2016 Apr; 43(4):227-31. PubMed ID: 27067042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunotherapy in follicular lymphoma.
    Illidge T; Morschhauser F
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):279-93. PubMed ID: 21658624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs).
    DeNardo GL
    Semin Nucl Med; 2005 Jul; 35(3):202-11. PubMed ID: 16098294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunotherapy for B-cell non-Hodgkin lymphoma.
    Witzig TE
    Best Pract Res Clin Haematol; 2006; 19(4):655-68. PubMed ID: 16997175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 131I-rituximab treatment in patient with relapsed non-Hodgkin's lymphoma: the first case report in Thailand.
    Kositwattanarerk A; Changmuang W; Sangsuriyan J; Thongklam K; Sritara C; Utamakul C; Chamroonrat W; Thamnirat K; Anongpornyochkul Y; Chancharunee S
    J Med Assoc Thai; 2013 Jun; 96(6):756-60. PubMed ID: 23951835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.